Provided by Tiger Trade Technology Pte. Ltd.

T. Rowe Price Health Care ETF

35.87
-0.0212-0.06%
Post-market: 35.85-0.0236-0.07%16:10 EDT
Volume:2K
Turnover:80.40K
Market Cap:31.39M
PE:- -
High:35.90
Open:35.74
Low:35.70
Close:35.89
52wk High:36.72
52wk Low:24.99
Shares:875.00K
Float Shares:875.00K
Volume Ratio:0.17
T/O Rate:0.26%
Dividend:0.16
Dividend Rate:0.45%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Lindian locks in early feed for Kazakh heavy rare earths plant

The West Australian
·
Aug 31

Thermo Fisher Scientific (TMO) Launches New Research Tools As Fair Value Debate Tightens

Simply Wall St.
·
Aug 30

Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run

Simply Wall St.
·
Aug 30

UnitedHealth Group (UNH), Why Is The Market Paying Closer Attention Now?

Simply Wall St.
·
Aug 30

Abbott, Vistra, Unity, United, Nu: Insider Shockwave

TIPRANKS
·
Aug 29

UnitedHealth, Strategy, Home Depot, Rocket Lab, Applied Shock

TIPRANKS
·
Aug 29

Pharma Industry Stares Down Biggest Patent Cliff in Decades

Dow Jones
·
Aug 29

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 29

Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 29

Eli Lilly (LLY) Wins FDA Approval For Mounjaro Heart Risk Reduction

Simply Wall St.
·
Aug 29

Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo

TIPRANKS
·
Aug 29

Sector Update: Health Care Stocks Mixed Pre-Bell Friday

MT Newswires Live
·
Aug 28

FDA Approves Lilly's Mounjaro to Cut Cardiovascular Event Risk in High-Risk Type 2 Diabetes Adults

Reuters
·
Aug 28

FDA Approves Lilly's Mounjaro (Tirzepatide) to Reduce Cardiovascular Risk in Adults with Type 2 Diabetes

THOMSON REUTERS
·
Aug 28

Bernstein Issues a Buy Rating on UnitedHealth (UNH)

TIPRANKS
·
Aug 28

Dow Jones Top Company Headlines at 11 PM ET: Judge Rules Trump Administration's Blacklisting of Anthropic was Unlawful | Nvidia ...

Dow Jones
·
Aug 28

Gilead Breaks Ground on Foster City Biologics Facility in $32 Billion US Investment Push

Reuters
·
Aug 28

Gilead Sciences Director Anthony Welters Disposes of USD 2.64 Million in Common Shares

Reuters
·
Aug 28

Gilead’s Bixlenvo approved by FDA for virologically suppressed adults with HIV

TIPRANKS
·
Aug 28

US FDA Approves Gilead's Once-Daily Combination Pill for HIV Treatment

Reuters
·
Aug 28